: Cells at the edge of seeded colonies acquire morphological characteristics of mesenchymal cells a) Brightfield images of MCF10A cells at the center and edge of spontaneous or TGF-β exposed colonies (200 µm scale bar, representative fields from 2 independent experiments and 6 images collected at similar coordinates between conditions). b) Zoom-in of images as outlined in yellow boxes from a. c) Brightfield images on MCF10A cells cultured at low and high confluence confluence for 7 days (200 µm scale bar, representative fields from 2 independent experiments and 4 images collected at similar areas of the plate between conditions). d) Histograms of ecadherin (top panel) and vimentin (bottom panels) protein levels in MCF10A cells seeded according to our spatial assay as well as MCF10A cells passaged every 96 hours and maintained at low (left panels) or high (right panels) confluence. Supplementary Figure 2: Expression of epithelial markers suggest that EMT is a continuum a-b) tSNE embedding of cells from our spontaneous EMT assay colored by CDH1 (a) or DSP (b) expression Supplementary Figure 3: Cells from inner and outer cell fractions are differentially distributed across pseudospace Distribution of inner (top) and outer (bottom) cells across our spontaneous EMT pseudospatial trajectory. Supplementary Figure 9: Pseudospatial trajectory reconstruction of primary human mammary epithelial (HuMEC) cells undergoing spontaneous EMT a) Trajectory of inner and outer HuMEC cells upon spontaneous EMT progression. Arrow denotes the progression of pseudoposition along the tree. b) Distribution of inner (top) and outer (bottom) cells across the pseudospatial trajectory. c) Distribution of CDH1, VIM and CDH1/VIM double positive cells across pseudospace. Pseudospace was divided into 5 quantiles, cells expressing CDH1 and VIM over their respective mean expression levels were identified and the fraction of cells positive for CDH1, VIM or both were plotted.
Supplementary Figure 4: Monocle does not identify a continuously populated trajectory for the subset of cells at the endpoints of spontaneous EMT
Although our spontaneous trajectory supports the view of a continuous EMT process we sought to ensure that it is not a result of Monocle arbitrarily connecting cells from a discrete EMT process. We selected cells in the first and last decile across pseudospace to simulate sampling from two distinct biological states and repeated our trajectory reconstruction with the expectation that a trajectory rom our subsetted cells should not be continuously populated. (a) Trajectory of subsetted inner and outer MCF10A cells upon spontaneous EMT progression. Note that the resulting trajectory from our subsetted cells contains a large gap in its center with inner and outer colony cells clustered at each end. (b) Distribution of inner (top) and outer (bottom) cells across our spontaneous EMT pseudospatial trajectory of subsetted cells from (a).
Supplementary Figure 5: Distribution of classically defined intermediate EMT states in our spontaneous EMT trajectory
Distribution of CDH1, VIM and CDH1/VIM double positive cells across pseudospace. Pseudospace was divided into 5 quantiles, cells expressing CDH1 and VIM over their respective mean expression levels were identified and the fraction of cells positive for CDH1, VIM or both were plotted.
Supplementary Figure 6: Bulk averages of epithelial marker expression fail to capture the dynamics of spontaneous confluence-mediated EMT
Gene expression levels of epithelial (left) and mesenchymal (right) markers across averaged inner (blue, 2,440 cells) and outer (red, 2,564 cells) colony cells. Point within the violin depicts the mean expression level for each group with violin spanning the minimum and maximum expression value across cells.
Supplementary Figure 7: Expression kinetics of genes repressed during spontaneous EMT and serve as a signature for KRAS activation associated with an epithelial exit
Color denotes whether cells were isolated from the interior (blue) or exterior (red) of the colony.
Supplementary Figure 8: Expression kinetics of unfolded protein response genes activated during spontaneous EMT a)
Unfolded protein response genes, including the UPR transcriptional regulator ATF4, from figure 1g cluster 6 that are activated towards the end of pseudospace with similarly to genes associated with an induction of an EMT. b) Unfolded protein response genes from figure 1g, cluster 5 that are activated towards the end of pseudospace. Color denotes whether cells were isolated from the interior (blue) or exterior (red) of the colony. Figure 10 : Expression of mesenchymal markers across cells from our TGFß-driven EMT trajectory a-c) tSNE embedding of cells from our TGF-ß-driven EMT assay. Cells are colored by the fraction from which they were isolated or by FN1 (b) or VIM (c) expression. Figure 11 : Pseudospatial trajectory reconstruction of MCF10A cells undergoing TGF-ß-driven EMT a) Trajectory of inner and outer MCF10A cells upon confluence and TGF-ß induced EMT progression. Arrow denotes the progression of pseudoposition along the tree. b) Distribution of inner (top) and outer (bottom) cells across the pseudopositional trajectory. c) E-cadherin and DAPI staining of cells from the center, middle and edge of TGF-ß exposed MCF10A colony (50 µM scale bar, representative fields from 6 images collected across 3 independent samples). d) Expression of select epithelial and mesenchymal markers across pseudospace. Cells are colored by the fraction from which they were isolated as in b.
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Supplementary Figure 12: Pseudospatial trajectory reconstruction of HuMEC cells undergoing TGF-ß-driven EMT a) Trajectory of inner and outer HuMEC cells upon TGF-ß induced EMT progression.
Arrow denotes the progression of pseudoposition along the tree. b) Distribution of inner (top) and outer (bottom) cells across the pseudopositional trajectory. c) Expression of select epithelial and mesenchymal markers across warped pseudospace with cells colored by treatment condition.
Supplementary Figure 13: EMT and epithelial scores of MCF10A and HuMEC cells at the endpoints of spontaneous and TGF-ß-driven EMT trajectories a-b)
Normalized aggregate expression scores of Hallmarks EMT (a) and GO-BP epithelial (b) genes of MCF10A and HuMEC cells at early and late positions in pseudospatial trajectories (MCF10A: spontaneous EMT early = 462 cells, spontaneous EMT late = 558 cells, TGF-ß-driven EMT early = 286 cells, TGF-ß-driven EMT late = 486 cells; HuMEC: spontaneous EMT early = 149 cells, spontaneous EMT late = 777 cells, TGF-ß-driven EMT early = 733 cells, TGF-ß-driven EMT late = 800 cells). Boxplots depict the median score (bold line within box) with lower and upper hinges depicting the 25th and 75th percentiles, respectively. Two-tailed wilcoxon rank test.
Supplementary Figure 14: The difference in AUC between our aligned spontaneous and TGF-ß-driven EMT trajectories follows the expected significance-magnitude relationship
Volcano plot depicting the relationship between statistical significance and effect size as measured by our ΔAUC metric. Each dot represents an individual gene (12,606 genes). Genes are colored by whether they pass or fail our filtering criteria (likelihood ratio test, FDR q < 1x10 -10 & |ΔAUC| > 0.02).
Supplementary Figure 15: Expression kinetics of genes activated during late stages of TGF-ß-driven EMT and serve as a signature for KRAS activation and acquisition of a mature mesenchymal state
Color denotes whether cells were come from spontaneous (blue) or TGF-ß-driven (maroon) EMT samples. 
Supplementary
Supplementary Figure 20: Replicability of spatial differential gene expression between original and pooled loss of function spatial experiments a-b) Venn diagram demonstrating the overlap between spatially differentially expressed genes (DEGs) for our original experiment pertaining to Figures 1 and 2 and cells expressing nontargeting controls in our pooled loss of function screen for spontaneous (a) and TGF-ß-driven (b) EMT. c-d) Correlation between beta coefficients between cells from our original spatial experiments and cells expressing non-targeting controls for our original spatial DEGs for spontaneous (c) and TGF-ß-driven (d) EMT (Pearson's r and Pearson chi-square test p-value).
(e-f) Alignment plots of dynamic time warped trajectories illustrate the warping of non-targeting control cells from spontaneous (e) or TGF-ß-driven (f) EMT to their respective unedited counterparts from our original MCF10A experiments. (g) Alignment plot illustrating the warping of non-targeting control cells from our loss of function spontaneous EMT to our loss of function TGF-ß-driven EMT trajectory. Note that the cost of aligning non-targeting control cells from our loss of function to our original experiments is minimal compared to aligning between EMT conditions.
Supplementary Figure 21: Pseudospatial trajectory reconstruction of CROP-Seq edited cells undergoing spontaneous and TGF-ß-driven EMT a/d)
Trajectory of inner and outer CROP-Seq edited cells upon spontaneous and TGF-ß-driven EMT progression. Cells are colored according to pseudospatial region. b/e) Distribution of inner and outer cells amongst pseudospatial trajectories in the spontaneous (b) and TGF-ß-driven (e) conditions. Cells are colored by the fraction from which they were isolated. c/f) Expression of epithelial and mesenchymal markers across pseudospatial trajectories in the spontaneous (c) and TGF-ß-driven (f) conditions. Cells are colored by the fraction from which they were isolated.
Supplementary Figure 22: Differential gene expression as a function of edited cell number a-b)
Total number of DEGs vs total number of cells expressing guide RNAs against select cell surface receptors and transcription factors in our screen under spontaneous (a) and TGF-β (b) EMT conditions. c) Same as (b) with TGFBR1 and TGFBR2 knockouts removed.
Supplementary Figure 23: Loss of function of a subset of EMT regulators results in differential distribution of knockout cells across pseudospace
Significance of the distribution of sgRNA containing cells across CROP-seq pseudospatial reconstruction for cells in the spontaneous (13,854 cells) (a) and TGF-ß-driven (9,951 cells) (b) conditions (FDR < 0.1, empirical FDR was determined by the rate at which each target was more significantly distributed according to Chi-square compared to a random subset of non-targeting controls (NTC-decoy) across 1000 iterations. (c) List of knockouts that are enriched in both spontaneous and TGF-ß-driven EMT conditions.
Supplementary Figure 24: Distribution of edited cells along pseudospatial trajectories reveals accumulation at various areas within the EMT continuum
Density plots of the distribution of cells expressing sgRNAs to the specified target or non-targeting controls under spontaneous and TGF-ß-driven EMT conditions. Shaded area corresponds to pseudospatial region(s) wherein EGFR and MET (a) or TGFBR1 and TGFBR2 (b) show accumulation according to our analysis.
Supplementary Figure 25: Distribution of classically defined intermediate EMT states in confluence and TGF-ß-driven EMT CROP-Seq trajectories
Distribution of CDH1, VIM and CDH1/VIM double positive cells across pseudospatial regions for spontaneous (a) or TGF-ß-driven (b) EMT trajectories. Pseudospace was divided into regions depending on the density of cells across pseudospace, cells expressing CDH1 and VIM over their respective mean expression levels were identified and the fraction of cells positive for CDH1, VIM or both were plotted.
Supplementary Figure 26: Dose response curves of MCF10A cells to increasing concentrations of select inhibitors targeting proteins associated with KRAS/MEK/ERK signaling
Dose response curves obtained from treatment of MCF10A cells with the specified concentration of small molecule inhibitor for 96 hours. Control growth was assessed measuring ATP levels via the Cell Titer-Glo colorimetric assay (n = 3, culture replicates). Luminescence values for each drug dose combination were normalized to DMSO control. For every dose tested, point depicts the mean control growth, error bars depict standard deviation of the mean.
Supplementary Figure 27: MEK kinase inhibition decreases the acquisition of mesenchymal traits in HuMEC cells
Percent vimentin (top panel) or cytoplasmic fibronectin (bottom panel) positive cells in HuMEC colonies exposed to MEK (U0126) inhibition after spontaneous (Control and U0126) or TGF-ßdriven (TGFβ and U0126 + TGFβ) EMT. Error bars denote standard deviation from the mean (n = 3 independent samples, , two-tailed Student's t-test). Figure 28 : EGFR signaling is necessary for exit from an epithelial state during spontaneous EMT in MCF10A cells a) EMT marker protein levels in cells undergoing spontaneous EMT in the absence and presence of 500 nM of the EGFR inhibitor erlotinib. Error bars denote standard deviation from the mean (n = 3 independent samples, two-tailed Student's t-test). (b) Representative flow cytometry histograms of EMT marker protein levels from (a). (c) Representative brightfield images of cells at the boundary of our spontaneous EMT colonies in the absence and presence of erlotinib for the experiments described in (a) and (b) (200 µm scale bar, representative fields from 12 images collected, n = 3 independent experiments). Red dots have been placed immediately next to cells which do not appear to have cell-cell attachments to other cells in the colony and represent mesenchymal cells that have migrated away from the colony. Note the drastic reduction in these cells upon EGFR inhibition.
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